Lyndsey Sarah Mixson

Ms. Lyndsey Sarah Mixson

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 February 2024 in Social Science & Medicine
Verified
Journal Article
Closed access
TSThomas J Stopka
Thomas J Stopka
AEA.T. Estadt
A.T. Estadt
GLG. Leichtling
G. Leichtling
JSJ.C. Schleicher
J.C. Schleicher
LMLyndsey Sarah Mixson
Lyndsey Sarah Mixson
RFR.J. Fredericksen
R.J. Fredericksen

30 May 2025 in International Journal of Drug Policy
Verified
Journal Article
Closed access
LMLyndsey Sarah Mixson
Lyndsey Sarah Mixson
WZWilliam Zule
William Zule
SRStephanie A. Ruderman
Stephanie A. Ruderman
JFJudith Feinberg
Judith Feinberg
TSThomas J. Stopka
Thomas J. Stopka
JDJoseph Delaney
Joseph Delaney

Verified
Journal Article
Open access
PDF file
TSThomas J Stopka
Thomas J Stopka
RNRobin M. Nance
Robin M. Nance
LMLyndsey Sarah Mixson
Lyndsey Sarah Mixson
HSHunter Cliffton Spencer
Hunter Cliffton Spencer
JTJudith I Tsui
Judith I Tsui
PFPeter D. Friedmann
Peter D. Friedmann
Limited research has examined the possible synergistic interrelationships between serious bacterial infections (SBIs) of the heart (i.e., endocarditis), bone, spine, brain, or joints (e.g., osteomylelitis) and hepatitis C virus (HCV) infections. We examined whether syndemic interactions existed between SBI, HCV, and substance-use-related factors in rural communities, hypothesizing that injection-mediated risks elevated the likelihood for both SBIs and HCV infections, which could be exacerbated by synergistic biological–biological or biological and social interactions. We calculated the prevalence ratios (PRs) of past-year SBI associated with each risk factor in separate models. Effect modification among significant risk factors was assessed using multiplicative interaction. Among 1936 participants, 57% were male and 85% White, with a mean age of 36 years. Eighty-nine participants (5%) reported hospitalization for an SBI in the year prior to the survey. More than half tested HCV-antibody-positive (58%); 62 (5.6%) of the participants with a positive HCV antibody result reported past-year hospitalization with an SBI. Injection behaviors were correlated with other SBI risk factors, including multiple injections in the same injection event (MIPIE), injection equipment sharing, and fentanyl use. In adjusted models, MIPIE (PR: 1.79; 95% confidence interval [CI]: 1.03, 3.11) and fentanyl use (PR: 1.68; 95% CI: 1.04, 2.73) were significantly associated with past-year SBI. Our analyses pointed to co-occurring epidemics of SBI and HCV, related to the cumulative health effects of fentanyl use contributing to frequent injections and MIPIE. Both the SBI and HCV epidemics present public health challenges and merit tailored interventions.

1 January 2024 in Substance Use: Research and Treatment
Verified
Journal Article
Open access
LMLyndsey Sarah Mixson
Lyndsey Sarah Mixson
BWBridget M Whitney
Bridget M Whitney
WJWiley D Jenkins
Wiley D Jenkins
TSThomas J Stopka
Thomas J Stopka
PKP Todd Korthuis
P Todd Korthuis
JDJoseph A Delaney
Joseph A Delaney
Background: The United States’ (US) opioid overdose epidemic has evolved into a combined stimulant/opioid epidemic, a pattern driven in part by mitigating opioid overdose risk, variable substance availability, and personal preferences. This study aimed to investigate the association between self-reported substance preference (heroin or methamphetamine) and behavioral/health outcomes among individuals who used both heroin and methamphetamine in the rural US. Methods: The Rural Opioid Initiative is a consortium of 8 research cohorts from 10 states and 65 rural counties that recruited individuals reporting past 30-day injection of any substance or opioid substance use by any route from 1/2018 to 3/2020. Analyses were restricted to participants ⩾18 years, who self-reported either heroin or methamphetamine as their preferred substance and past 30-day use of both heroin and methamphetamine. We examined cross-sectional associations between preferred substance (heroin versus methamphetamine) and behavioral and health outcomes using random effects meta-analysis with adjusted regression models. Results: Among 1239 participants, 61% (n = 752) reported heroin as their preferred substance. Adjusting for age, sex, and race/ethnicity, methamphetamine preference was associated with lower prevalence ratios for current naloxone possession (adjusted prevalence ratio [aPR] = 0.68; 95% Confidence Interval [95% CI] = 0.59-0.78; P-value ⩽ .001), of ever being told they had the hepatitis C virus (HCV; aPR = 0.72; 95% CI: 0.61-0.85; P-value ⩽ .001) and a personal history of overdose (aPR = 0.81; 95% CI = 0.73-0.90; P-value ⩽ .001). Conclusion: In our study analyzing associations between preferred substance and various behavioral and health outcomes amongst people who use both heroin and methamphetamine, a majority of participants preferred heroin. Methamphetamine preference was associated with lower prevalence of naloxone possession, ever being told they had HCV, and prior history of an overdose. This study underscores the need for targeted harm reduction services for people who prefer methamphetamine in rural areas.

30 April 2025 in Substance use & addiction journal
Verified
Journal Article
Closed access
LMLyndsey Sarah Mixson
Lyndsey Sarah Mixson
AVArvind Venkataraman
Arvind Venkataraman
LDLydia N. Drumright
Lydia N. Drumright
BWBridget M Whitney
Bridget M Whitney
WJWiley D. Jenkins
Wiley D. Jenkins
HCHeidi M. Crane
Heidi M. Crane
Background: Benzodiazepines and opioids are among the most frequently misused psychoactive substances, but their patterns of co-use (polysubstance use) in rural areas are unclear. As resources to address substance use are disproportionally scarce in rural areas, a better understanding of this polysubstance use is critical to allocate and direct interventions. Methods: The Rural Opioid Initiative comprises 8 research cohorts spanning 10 states and 65 rural counties. Participants were recruited from January 2018 to March 2020 and eligibility included past 30-day opioid use by any route or past 30-day injection of any substance. Analyses were restricted to participants reporting past 30-day opioid use and either benzodiazepine or stimulant use. We described bivariate cross-sectional associations between benzodiazepine+opioid use, compared with stimulant+opioid use, and substance use behaviors, health outcomes, injection drug use, addiction treatment, and criminal legal system involvement. Results: Of the 1107 ROI participants that met inclusion criteria, 10% (n = 107) reported benzodiazepine+opioid use, and 90% (n = 1000) reported stimulant+opioid use. The benzodiazepine+opioid group, compared with the stimulant+opioid group, had a higher use of opioid pain medication (73% vs 55%), gabapentin (43% vs 23%), and clonidine (12% vs 4%) to get high and used these substances more frequently; they also reported more frequent heavy episodic drinking (6.1 days per 30 days, SD = 9.4 vs 4.1 days, SD 7.5). The benzodiazepine+opioid group reported a lower prevalence in the past 6 months of law enforcement stop-and-search incidents (29% vs 48%), arrests (11% vs 28%), probation (22% vs 34%), jail/prison (18% vs 41%), and fewer days in jail/prison (4.7, SD = 19.1 days vs 15.9, SD = 35.7 days). Conclusion: We found that benzodiazepines+opioids use was associated with more heavy episodic drinking and gabapentin use, and lower prevalence of criminal legal system involvement. These data suggest that individuals reporting benzodiazepines+opioids use have distinct behavioral patterns and outcomes that require targeted interventions for rural populations.

10 July 2026 in Substance Use: Research and Treatment
Verified
Journal Article
Open access
LMLyndsey Sarah Mixson
Lyndsey Sarah Mixson
AYApril M. Young
April M. Young
JTJudith I. Tsui
Judith I. Tsui
WJWiley D. Jenkins
Wiley D. Jenkins
MPMai T. Pho
Mai T. Pho
HCHeidi M. Crane
Heidi M. Crane
Despite the recognition of substance use and sex work as public health issues, the intersection of these areas, especially within the rural US, is an area of special importance. The Rural Opioid Initiative comprises of eight research cohorts spanning 10 states and 65 rural US counties. Between 1/2018-3/2020, individuals who reported past 30-day substance injection or opioid misuse were recruited. Analyses were restricted to people who use drugs (PWUD) who reported trading “vaginal or anal sex for drugs, money, housing, or other things you need” in the past 30 days. We analyzed cross-sectional associations between injection drug use and sexual behaviors associated with hepatitis C virus (HCV)/HIV infection transmission, access to harm reduction, and HCV status among PWUD and engaged in sex work in rural US areas. Of the 2045 participants, 9% (n=180) reported engagement with sex work, with just over half being women (58% [n=104]). In adjusted models, people who engaged in sex work, compared to PWUD who did not, had higher prevalence ratios of past 30-day receptive syringe sharing (adjusted prevalence ratio [aPR]=1.69, 95% Confidence Interval [95%CI]=1.44–1.98), practice of multiple injections per injection episode (aPR = 1.28, 95% CI = 1.15–1.43), practice of syringe mediated drug sharing (aPR=1.50, 95% CI=1.32–1.71), condomless sex (aPR=1.62, 95% CI=1.48–1.77) and condomless sex with someone who injects drugs (aPR=2.05, 95% CI=1.76–2.39). PWUD engaged in sex work were less likely to report easy condom access (aPR=0.88, 95% CI=0.80–0.96), while no significant differences were observed for most other harm reduction access measures. PWUD engaged in sex work in the rural US had higher likelihood of injection drug use and sexual behaviors associated with HCV/HIV infection transmission, while having lower use of and access to condoms. This study emphasizes the importance of ensuring affordable access to condoms within the context of harm reduction services, especially given the limited access to health care and supportive services, particularly in rural communities.